Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / STAB - Statera Biopharma receives Nasdaq notice regarding 10-K filing

STAB - Statera Biopharma receives Nasdaq notice regarding 10-K filing

Statera Biopharma Inc.
Statera Biopharma (NASDAQ:STAB) receives Nasdaq notice as it has not yet filed its annual report for the fiscal year ended December 31, 2021. As of March 31, 2022, company was unable to file its Form 10-K within the prescribed time period due to a delay in completing its financial statements and other disclosures. Nasdaq had granted an exception giving a new deadline of April 15, 2022. Company has until June 20, 2022 to submit a plan to regain compliance. Stock drops 3.3% during after hours.

For further details see:

Statera Biopharma receives Nasdaq notice regarding 10-K filing
Stock Information
Company Name: Statera Biopharma Inc.
Stock Symbol: STAB
Market: OTC
Website: staterabiopharma.com
Menu
STAB STAB Quote STAB Short STAB News STAB Articles STAB Message Board
Get STAB Alerts

News, Short Squeeze, Breakout and More Instantly...